Management of RA, OA, SLE, Gout Flashcards
Criteria for clinical diagnosis of gout
- Hx at least 2 attacks of painful joint swelling
- Hx of podagra at 1st MTP
- Presence of tophi
- Rapid response to colchicine
Characteristics of gouty tophi
- Firm
- Nodular/ Fusiform swelling
- Painless
- Subcutaneous
Investigation to confirm gout (Gold Standard)
- Serum uric acid
- male & post menopausal women > 7mg/dL
- pre menopausal women > 6mg/dL - Joint aspiration
- presence of monosodium urate crystal
Investigation to look for associated condition to gout
- FBC - TRO infection
- Serum Urea/Creatinie - TRO renal dz causing hyperuricemia
- Blood Glucose - Assess for DM
- UFEME - Blood & protein (renal dz)
MSU crystal vs CPPD crystal shape
MSU - Slender needles & rods
CPPD - Small, rhomboid
Findings of acute & chronic gout on xray
Acute - Soft tissue swelling
Chronic
- Tophi
- Punched out articular bone lesion
- Preserved joint space
Acute gout flare management principles
- Pill in the pocket - Colchicine, NSAIDs, Steroids
- Choice of drug - depend on pt
- Adjunctive - drink lots of water
- Urate lowering therapy - Allopurinol
Guideline for Gout Management
2020 ACR Guideline for Gout Management
Indication to Initiate ULT (Allopurinol):
1. 1/more subcutaneous tophi
2. Radiographic damage
3. Frequent gout flares, > 2 years
- Avoid ULT in first presentation of gout
Uric acid lowering strategies
- Inhibit uric acid production - Allopurinol
- Promote uric acid excretion - Probenecid
- Convert uric acid to allantoin
Severe cutaneous adverse reaction (SCAR) of Allopurinol & alternative management
- Toxic Epidermal Necrolysis (TENs)
- Steven JOhnson SYndrome (SJS)
- Allopurinol Hypersensitivity Syndrome (AHS)
- change allopurinol to febuxostat
Possible colchicine side effect
- diarrhea
- nausea & vomiting
- marrow suppression
What is asymptomatic hyperuricemia, do we treat it with allopurinol?
Asymptomatic hyperuricemia
- High uric acid, without gout attacks
X start allopurinol
- harm outweughs benefit
Serum uric acid target for acute & chronic gout
Acute: SUA < 360 umol/L
Chronic: SUA < 300 umol/L
Risk factor of RA
- Increasing age
- Female
- First degree relative
- Smoking
Characteristics of RA bone
- Pannus
- Synovial hyperplasia
- Cartilage damage
- Bone matrix destruction
Imprtant test for RA in physical examination & finding
Squeeze test (at MCP & MTP)
- tenderness
Common deformity in RA
- Fusiform swelling (PIP)
- Boutonniere deformity - weak central slip of EET
- Swan neck deformity - flexor contraction
- Ulnar deviation - subluxation of MCPJ
- Z deformity
- Piano key ulnar head
- Claw toe
Xray finding of RA (ABCDES)
Alignment
Bones - Juxta-articular osteopenia
Cartilage - uniform loss of joint space
Deformities
Erosions - Margina
Soft tissue swelling
Non pharmacological treatment of RA
- Lifestyle changes - stop smoking
- Physiotheraphy
Pharmacological treatment of RA
First line: DMARDs
Second line: Biologic DMARDs / Targeted DMARDs
Add on: NSAIDs for pain, corticosteroids (prednisolone)
4 types of DMARDs (Disease Modifying Anti Rheumatic Drugs)
- Conventional DMARDs
- Targeted synthetic DMARDs
- Biologic DMARDs
- Biosimilar DMARDs
4 commonly used conventional DMARDs
- Methotrexate
- Sulfasalazine
- Hydroxychloroquine
- Leflunomide
Side effect of Methotrexate & prophylaxis
Folic acid reduction: Ulcers in mouth, Low HB
Prophylaxis: Folic acid 5mg /week
What is PsA
- Chronic, progressive, inflammatory disorder of joint & skin
- Characterized by osteolysis & bony proliferation